Johnson & Johnson (JNJ) is a household name thanks to products like Band Aid, Tylenol, and Benadryl. The company also has prescription pharmaceuticals and medical device divisions as well. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
The fundamentals toward JNJ are incredibly strong, especially for a company that has been around for over 130 years.
The return on equity is 56.9%, the profit margin is 31.7% and the operating margin is 25.1%. The earnings per share have been growing at a rate of 5% over the past three years and analysts expect them to grow at a rate of 7.8% over the next five years.
JNJ has formed a trend channel on its weekly chart that goes all the way back to the fourth quarter of 2015. The stock did drop below the trend channel and below its 52-week moving average yesterday, but it did recover some of the losses and closed back up at the lower rail of the channel and just below the moving average.
The sentiment toward JNJ has become decidedly more bearish in recent weeks and the SentimenTrader optix reading hit an extreme low last Friday. In fact the sentiment was at its lowest level since August ’15.
Suggested strategy: Buy JNJ with a maximum entry price of $135.00. I would set a target of at least $170 in the next six months, for a 30% potential return from current prices. I would also set a stop-loss at $115.
— Rick Pendergraft
Where to Invest $99 [sponsor]Motley Fool Stock Advisor's average stock pick is up over 350%*, beating the market by an incredible 4-1 margin. Here’s what you get if you join up with us today: Two new stock recommendations each month. A short list of Best Buys Now. Stocks we feel present the most timely buying opportunity, so you know what to focus on today. There's so much more, including a membership-fee-back guarantee. New members can join today for only $99/year.